FDA Approves Apalutamide (Erleada); the first treatment for non-metastatic castration-resistant prostate cancer (READ MORE HERE).
New therapeutics are urgently needed for hormone..
Justine Bruce, MD:
University of Wisconsin Carbone Comprehensive Cancer Center – Madison, WI
Glenn Liu, MD, Associate Professor of Medicine, Section of Medical Oncology and Hematology, at the University of Wisconsin Carbone Comprehensive Cancer Center.
Dr. Beltran’s research will help define the..
Himisha Beltran, MD:
Weill Cornell Medical College – New York, NY
David Nanus, MD, Medical Director of the Genitourinary Oncology Program and Chief of the Division of Hematology and Medical Oncology at Weill Cornell Medical College.
Mark Rubin, MD, Professor of Pathology and Laboratory Medicine, Director of Translational Research Laboratory Services, and Vice Chairman for Experimental Pathology at Weill Cornell Medical College.
More than 50% of prostate cancers have..
The 2011 Cayre Family Foundation – PCF Young Investigator Award (second year)
The 2011 Robert Kraft – PCF Young Investigator Award (third year)
John Chadwick Brenner, MSc, PhD:
University of Michigan
Arul Chinnaiyan, MD, PhD
Dr. Christopher Barbieri, under the mentorship of..
Christopher Barbieri, MD, PhD:
Weill Cornell Medical College
Mark Rubin, MD
Dr. Bajor, under the mentorship of Dr...
David Bajor, MD:
University of Pennsylvania
Robert Vonderheide, MD, DPhil and Carl June, MD
Dr. Bismar earned an MD degree from..
Tarek Bismar, MD:
University of Calgary – Canada
T cells are a type of immune..
W. Nathaniel Brennen, PhD:
The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
John Isaacs, PhD, Charles Drake, MD, PhD
T cells Engineered to Selectively Deliver a PSA-activated Protoxin to Sites of Advanced Prostate Cancer
Approximately 25% of patients who fail Xtandi..
Jennifer Bishop, PhD:
University of British Columbia
Martin Gleave, MD and Amina Zoubeidi, PhD
Regulation of cell plasticity by the androgen receptor: A novel mechanism of enzalutamide (Xtandi) resistance
This talented team of scientists who have..
Johann S. de Bono, MD, PhD –:
The Institute of Cancer Research and The Royal Marsden Hospital Identification, Characterization and Validation of Novel Inhibitors of the AR N-Terminus
Gerhardt Attard, MD, PhD; Jun Luo, PhD; Michael Carducci, MD; Mario Eisenberger, MD; Peter Campbell, PhD
Abiraterone acetate (Zytiga), recently approved by the..
Steven Balk, MD, PhD –:
Beth Israel Deaconess Medical Center
Identifying and Exploiting Mechanisms of Response and Resistance to Androgen Receptor Pathway Directed Therapeutics
Peter Nelson, MD; Trevor Penning, PhD; Glenn Bubley, MD; Toni Choueiri, MD; Phillip Kantoff, MD; Christopher Sweeney, MD; Mary-Ellen Taplin, MD; Steven Plymate, MD; Robert B. Montgomery, MD; Robert Vessella, PhD; Lawrence True, MD; Alvin Matsumoto, MD; Elahe Mostaghel, MD, PhD
“I think those of us who do..
To honor his grandfather, who passed away..
Bassini & Company
Domain Associates, LLC
Founder and Chief Executive Officer
Burd Health LLC